Company page

Canbridge Pharmaceuticals Inc.

Canbridge Pharmaceuticals Inc. is a public company listed on the Hong Kong Stock Exchange under the ticker 1228. The company has a market capitalization of approximately HKD 151.16 million. Canbridge focuses on developing innovative therapies for patients with rare diseases and unmet medical needs.

profile1228:HKEXAI content: aiUpdated June 24, 2026/company/canbridge-pharmaceuticals-inc-1/c-4gma7ihg
Canbridge Pharmaceuticals Inc. logo
Ticker
1228:HKEX
Asset type
Stock
Market cap
$151.2M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
HKEX
Currency
HKD